Wolverine Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Wolverine Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-15,580	Closed	-$1.48M	–	1726
2019 Q4	$1.48M	Sell	15,580 -5,900	-27%	-$510K	0.02%	519
2019 Q3	$1.64M	Buy	21,480 +5,000	+30%	+$416K	0.02%	473
2019 Q2	$1.45M	Hold	16,480	–	–	0.02%	528
2019 Q1	$1.49M	Buy	16,480 +3,600	+28%	+$306K	0.02%	517
2018 Q4	$924K	Buy	12,880 +3,700	+40%	+$298K	0.01%	845
2018 Q3	$880K	Buy	+9,180	New	+$890K	0.01%	855
2017 Q3	–	Sell	-14,762	Closed	-$1.18M	–	1518
2017 Q2	$1.14M	Buy	+14,762	New	+$1.05M	0.01%	581

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Wolverine Asset Management's XBI Position: Q1 2020 in Review

Wolverine Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2020, closing a stake of 15,580 shares — an estimated $1.48M sold.

Wolverine Asset Management first reported a position in XBI in Q2 2017 and held it in 7 quarters. The position peaked at $1.64M in Q3 2019. 458 funds tracked by Wall St. Rank hold XBI as of Q1 2020.

Wolverine Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2020 after selling out during the quarter.
Wolverine Asset Management sold 15,580 State Street SPDR S&P Biotech ETF shares in Q1 2020, an estimated $1.48M.
Wolverine Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and held it in 7 quarters.
Wolverine Asset Management's State Street SPDR S&P Biotech ETF position peaked at $1.64M in Q3 2019.
458 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2020.

Based on Wolverine Asset Management's 13F filing for Q1 2020, filed 13 May 2020.